Forgot Password?
Return to Course Listing

CME: Psoriasis: Best Practices, Barriers to Care, and Emerging Therapies

ACCREDITATION EXPIRED: June 30, 2016

Activity Description / Statement of Need:

In this online CME self-learning program:

 

Psoriasis, characterized by chronic inflammation of the skin and hyperproliferation and abnormal differentiation of the stratified epidermis, is one of the most common autoimmune disease in the U.S.  It presents clinically as red, scaly plaques on the skin and ranges in severity from minor, localized lesions to complete body coverage.  It is also associated with inflammation of the joints and enthesial attachments and has potential of articular destruction, a complication known as psoriatic arthritis that affects up to 30-40% of those with the disease. Treatment for psoriasis include biological agents, phototherapy, traditional systemic drugs, topical steroids and topical non-steroids.

 

Identifying the severity of psoriasis remains key in choosing the right medication; doing so is still predominantly based on the rule of nine in determining the percentage of body surface area affected. Literature suggests that correct evaluation of lesion sizes, a precise calculation of the treatments quantity to be prescribed, clear instructions, and treatment-specific individual dosing devices may help achieve higher rates of adherence and treatment success.

 

Agenda:

 

Epidemiology and risk factors for psoriasis

  • Statistics
  • Gender and age disparity
  • Comorbidities associated with psoriasis (obesity, diabetes, etc)
  • Genetics
  • Modifiable risk factors (stress, diet, etc.)

Review and updates in symptomology and diagnostic considerations

  • Signs and symptoms of psoriasis lesions
  • Common locations of the body psoriasis lesions observed
  • Triggers associated with psoriasis (stress, injury to skin, etc.)
  • Types of psoriasis
  • The Psoriasis Area and Severity Index (PASI) score

Treatment options in patients with psoriasis

  • Role of biologic drugs, present and emerging
  • Role of topical steroid and non-steroid formulations
  • Role of conventional systemic drugs
  • Role of phototherapy
  • Role of complementary and alternative medications (diet, mind/body therapies)
  • Best practice: putting it all together
  • Patient case(s)

Barrier to optimal care in patients with psoriasis

  • Adherence to therapy
  • Cost
  • Modifiable risk factors
  • Patient case(s)

Target Audience:

Healthcare professionals specializing in: allergy, dermatology, immunology, internal and family medicine, and those who otherwise may treat patients with psoriasis.

This program is supported by an educational grant from AMGEN.

Release Date: June 30, 2014 -- Expiration Date: June 30, 2016

Faculty: Jennifer Soung, MD

Agenda

Learning Objectives

By the end of the session the participant will be able to:

  • Describe challenges to effective diagnosis of psoriasis.
  • Identify present and emerging treatment strategies for psoriasis, weighing their risk-benefit profiles in the setting of patient cases
  • Recognize the appropriate therapeutic choices in individual patients with psoriasis based on their demographic and clinical characteristics, applying them to patient cases.
  • Discuss emerging therapies and their potential place(s) in therapy in psoriasis.
  • Develop strategies to minimize adverse effects and barriers to care associated with psoriasis treatment(s).

Accreditation

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.


Faculty Disclosure and Resolution of COI

 As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

 

Faculty Disclosures:  

 

Jennifer Soung, MD has is a consultant or has received Research and Educational Grants from Amgen, Pfizer, Janssen,  Celgene, and Abbvie

 

Disclosures of Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.

 

Commercial Support Disclosure: This program is supported by an educational grant from AMGEN.

Instructions

  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

PC
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
MAC
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.